Mild to Moderate Hypertension Clinical Trial
Official title:
A Phase 1/2, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacodynamics, and Pharmacokinetics of Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacodynamics (PD) and pharmacokinetics (PK) of zilebesiran in Japanese patients with mild to moderate hypertension.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01601470 -
Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension
|
Phase 2 | |
Recruiting |
NCT05530512 -
Acupuncture Therapy and Hypertension
|
N/A |